StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Artelo Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Artelo Biosciences's price to book ratio was 0.3× on Nov 11, 2026, against 34.4× a year earlier. Over the last 5 years it ranged from 0.3× to 479.1×, with a median of 13.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−268.7
2025Jul 31, 2025269.0×+254.5
2024Dec 31, 202414.5×+6.3
2023Dec 29, 20238.2×−2.4
2022Dec 30, 202210.6×−17.9
2021Dec 31, 202128.5×−352.3
2020Dec 31, 2020380.8×−114.2
2019Oct 31, 2019495.0×–

More Artelo Biosciences figures

See a number that looks wrong?